Alveolar Rhabdomyosarcoma Treatment; Depends On the Size, Location, and Stage of the Tumor
Alveolar Rhabdomyosarcoma Treatment often includes surgery, chemotherapy, and radiation therapy (radiotherapy). Moreover, the treatment of rhabdomyosarcoma has greatly improved the care of patients over the past few decades. Around 80% of patients with rhabdomyosarcoma (low-risk) can now be cured. Alveolar rhabdomyosarcoma (ARMS) refers to one subtype of the rhabdomyosarcoma family of soft tissue tumors. While, rhabdomyosarcoma is a rare type of cancer that forms in soft tissue; may occur at any age, often affects children. Alveolar Rhabdomyosarcoma Treatment , such as chemotherapy, is given by injection into a vein. In North America, drugs such as cyclophosphamide (Neosar, Clafen, Cytoxan,), dactinomycin (Cosmegen, Lyovac Cosmegen), and vincristine (Vincasar, Oncovin) are commonly used to treat rhabdomyosarcoma. This combination of drugs is often called Vincristine, actinomycin D, and cyclophosphamide (VAC), an abbreviation for a chemotherapy combination used to treat rhabdomyosarc